Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Making money from home in your spare time is possible. Explore various options that fit into your busy schedule.
24,286 articlesPfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Berkshire Hathaway under Greg Abel signals a sharper eye for AI champions. Could Alphabet be the catalyst, with Nvidi...
A new growth-focused ETF with a 0.03% expense ratio has posted strong five-year outperformance versus the S&P 500, le...
Alphabet reports results after the bell, but the line that matters most might be capex. This guide shows how data-cen...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
A practical, investor-friendly look at Gambling.com Group's Q1 2026 earnings. This deep dive breaks down revenue driv...
Get an in-depth look at Paysafe (PSFE) 2026 earnings outlook. We break down Q1 results, revenue streams, margin trend...
As consumer debt climbs, a sharp cost comparison shows bankruptcy can wipe out unsecured balances in months, while lo...
A historic step: Paxos earns SEC clearance to operate as a registered clearing agency. This milestone could reshape c...
A single conference-call moment changed the mood around Eli Lilly. By unpacking eight key themes from the CEO, invest...
When a board member snaps up thousands of shares as the stock falls, it sparks questions. This piece breaks down what...
The U.S. government has halted Anthropic's Fable 5 and Mythos 5, citing a security vulnerability. The move shakes fin...